BIBN 4096 BS - in single rising doses
Sponsors
Boehringer Ingelheim
Conditions
Healthy
Phase 1
Safety, Tolerability and Pharmacokinetics After Administration of Increasing Dose of BIBN 4096 BS in Healthy Male and Female Volunteers
CompletedNCT02194322
Start: 2001-11-30Updated: 2014-07-23
Safety, Tolerability and Pharmacokinetics of Increasing Doses of BIBN 4096 BS in Healthy Male and Female Volunteers
CompletedNCT02194335
Start: 2000-10-31Updated: 2014-07-23
Safety, Tolerability and Pharmacokinetics of Inhalative Administration of BIBN 4096 BS in Healthy Male and Female Volunteers
CompletedNCT02194777
Start: 2001-06-30Updated: 2014-07-23
Study to Determine Tolerability of Single Increasing Dose of BIBN 4096 BS in Healthy Male and Female Volunteers
CompletedNCT02194348
Start: 2000-02-29Updated: 2014-07-23
Study to Determine Tolerability After Intravenous Administration of BIBN 4096 BS in Healthy Male and Female Volunteers
CompletedNCT02198352
Start: 1998-06-30Updated: 2014-07-29